首页> 外文期刊>Pathology International >Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of 'benign' thyroid tumor (letter)
【24h】

Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of 'benign' thyroid tumor (letter)

机译:二肽基肽酶IV(DPP IV / CD26)染色可预测“良性”甲状腺肿瘤的远处转移(字母)

获取原文
获取原文并翻译 | 示例
           

摘要

Because follicular thyroid carcinoma is extremely difficult to diagnose, several cases were encountered which have been rediagnosed as carcinoma due to distant metastasis. In the search for a method of correctly diagnosing 'benign' thyroid tumor, dipeptidyl peptidase (DPP) IV immunostaining was applied to 10 cases whose diagnoses had been corrected to follicular thyroid carcinoma because of distant metastases. The positive rate of immunostaining using paraffin sections in the rediagnosed follicular thyroid carcinoma group (7/10) was much higher than that of the control group (1/29), which consisted of 15 cases of follicular thyroid adenoma and 14 cases of nodular hyperplasia. These results suggested that pre- or postoperative DPP IV staining is useful for predicting distant metastasis of 'benign' thyroid tumor.
机译:由于滤泡性甲状腺癌非常难以诊断,因此遇到了几例因远处转移而被重新诊断为癌的病例。在寻找正确诊断“良性”甲状腺肿瘤的方法中,二肽基肽酶(DPP)IV免疫染色被用于10例因远处转移而被诊断为滤泡性甲状腺癌的病例。重新诊断的滤泡性甲状腺癌组中使用石蜡切片的免疫染色阳性率(7/10)远高于对照组(1/29),其中由滤泡性甲状腺腺瘤15例和结节性增生14例组成。这些结果表明,术前或术后DPP IV染色可用于预测“良性”甲状腺肿瘤的远处转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号